1.Real-Life Clinical Use of Symbicort® Maintenance and Reliever Therapy for Asthmatic Patients in Korea
Sang Hoon KIM ; Tae Bum KIM ; Sang Heon KIM ; Heung Woo PARK ; Sook Hee SONG ; Jae Won JEONG ; Young Koo JEE ; Sang Won PARK ; Mi Sun KIM ; Ho Joo YOON
Allergy, Asthma & Immunology Research 2018;10(1):88-94
The aim of this study was to examine the daily practice patterns of Symbicort® Maintenance and Reliever Therapy (SMART) in Korean asthmatic patients and to analyze clinical signs related to overuse. This study used an observational, multicenter, noninterventional, prospective, uncontrolled design for examining asthmatic patients prescribed SMART to assess the frequency and pattern of Symbicort® usage as a maintenance and reliever medication. The characteristics of patients showing signs of overuse (frequency of inhalation: 8 or more times per day) were also analyzed. Among the 1,518 patients analyzed, 1,292 (85.1%) completed the trial. The number of mean inhalations per day was 2.14±1.15; the number of patients who had at least 1 as needed usage (PRN) inhalation per day was 843 (55.5%); the mean frequency of PRN use was 0.25±0.67 inhalations per day. The number of patients who overused for at least 1 day was 260 (17.1%). In particular, young patients, patients with limited physical activity, and patients with nocturnal symptoms demonstrated high frequency of overuse. The frequency of overuse during SMART was not high in Korean asthmatic patients and the asthma status of follow-up outpatients improved overall. However, there is a need for careful education targeted toward younger patients, patients with limited physical activity, and patients with nocturnal symptoms owing to their tendency to frequently overuse.
Asthma
;
Budesonide
;
Education
;
Follow-Up Studies
;
Formoterol Fumarate
;
Humans
;
Inhalation
;
Korea
;
Motor Activity
;
Outpatients
;
Prescription Drug Overuse
;
Prospective Studies
2.Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study.
Myoung Jin CHA ; Heui Soo MOON ; Jong Hee SOHN ; Byung Su KIM ; Tae Jin SONG ; Jae Moon KIM ; Jeong Wook PARK ; Kwang Yeol PARK ; Soo Kyoung KIM ; Byung Kun KIM ; Soo Jin CHO
Journal of Clinical Neurology 2016;12(3):316-322
BACKGROUND AND PURPOSE: Chronic daily headache (CDH) is defined as a headache disorder in which headaches occur on a daily or near-daily basis (at least 15 days/month) for more than 3 months. Chronic migraine (CM) and medication overuse headache (MOH) are very disabling headaches that remain underdiagnosed. The aim of this study was to establish the frequency of CDH and its various subtypes, and examine the associations with MOH among first-visit headache patients presenting at neurology outpatient clinics in Korea. METHODS: Eleven neurologists enrolled first-visit patients with complaints of headaches into outpatient clinics for further assessment. Headache disorders were classified according to the International Classification of Headache Disorder (third edition beta version) by each investigator. RESULTS: Primary CDH was present in 248 (15.2%) of the 1,627 included patients, comprising CM (143, 8.8%), chronic tension-type headache (CTTH) (98, 6%), and definite new daily persistent headache (NDPH) (7, 0.4%). MOH was associated with headache in 81 patients (5%). The association with MOH was stronger among CM patients (34.5%) than patients with CTTH (13.3%) or NDPH (14.3%) (p=0.001). The frequency of CDH did not differ between secondary and tertiary referral hospitals. CONCLUSIONS: The frequencies of CDH and MOH diagnoses were 15.2% and 5%, respectively in first-visit headache patients presented at secondary or tertiary referral hospitals in Korea. CM was the most common subtype of CDH and was most frequently associated with MOH.
Ambulatory Care Facilities
;
Classification
;
Diagnosis
;
Epidemiology
;
Headache Disorders*
;
Headache Disorders, Secondary*
;
Headache*
;
Humans
;
Korea*
;
Migraine Disorders
;
Neurology
;
Prescription Drug Overuse*
;
Research Personnel
;
Tension-Type Headache
;
Tertiary Care Centers
3.Comprehensive review and update on chronic migraine
Journal of the Korean Medical Association 2018;61(5):314-322
Chronic migraine (CM) is a common and disabling neurologic disorder. CM is defined as more than 15 days a month over a 3-month period, including at least 8 days per month on which their headaches and associated symptoms meet diagnostic criteria for migraine. Quality of life is highly compromised in patients with this condition, and comorbidities are more frequent than with episodic migraine. The diagnosis requires a carefully-conducted patient interview and neurologic examination, sometimes combined with additional diagnostic tests, to differentiate CM from secondary headache disorders and other primary chronic headaches. CM typically develops from episodic migraine over months to years. Several factors are associated with an increased risk of episodic migraine developing into CM, including the frequent use of abortive migraine drugs. Through identification of risk factors for progression to CM, clinicians can educate patients about modifiable risk factors and can begin appropriate individualized preventive therapy. There is a high frequency of medication overuse in CM. The first step in the management of CM complicated by medication overuse is withdrawal of the overused drugs and detoxification treatment. This article provides an overview of CM, including its epidemiology, risk factors for its development, and information on its pathophysiology, diagnosis, and management.
Comorbidity
;
Diagnosis
;
Diagnostic Tests, Routine
;
Epidemiology
;
Headache
;
Headache Disorders
;
Headache Disorders, Secondary
;
Humans
;
Migraine Disorders
;
Nervous System Diseases
;
Neurologic Examination
;
Prescription Drug Overuse
;
Quality of Life
;
Risk Factors
4.Characteristics of Elderly-Onset (≥65 years) Headache Diagnosed Using the International Classification of Headache Disorders, Third Edition Beta Version.
Tae Jin SONG ; Yong Jae KIM ; Byung Kun KIM ; Byung Su KIM ; Jae Moon KIM ; Soo Kyoung KIM ; Heui Soo MOON ; Myoung Jin CHA ; Kwang Yeol PARK ; Jong Hee SOHN ; Min Kyung CHU ; Soo Jin CHO
Journal of Clinical Neurology 2016;12(4):419-425
BACKGROUND AND PURPOSE: New-onset headache in elderly patients is generally suggestive of a high probability of secondary headache, and the subtypes of primary headache diagnoses are still unclear in the elderly. This study investigated the characteristics of headache with an older age at onset (≥65 years) and compared the characteristics between younger and older age groups. METHODS: We prospectively collected demographic and clinical data of 1,627 patients who first visited 11 tertiary hospitals in Korea due to headache between August 2014 and February 2015. Headache subtype was categorized according to the International Classification of Headache Disorders, Third Edition Beta Version. RESULTS: In total, 152 patients (9.3%, 106 women and 46 men) experienced headache that began from 65 years of age [elderly-onset group (EOG)], while the remaining 1,475 patients who first experienced headache before the age of 65 years were classified as the younger-age-at-onset group (YOG). Among the primary headache types, tension-type headache (55.6% vs. 28.8%) and other primary headache disorders (OPH, 31.0% vs. 17.3%) were more common in the EOG than in the YOG, while migraine was less frequent (13.5% vs. 52.2%) (p=0.001) in the EOG. Among OPH, primary stabbing headache (87.2%) was more frequent in the EOG than in the YOG (p=0.032). The pain was significantly less severe (p=0.026) and the frequency of medication overuse headache was higher in EOG than in YOG (23.5% vs. 7.6%, p=0.040). CONCLUSIONS: Tension-type headache and OPH headaches, primarily stabbing headache, were more common in EOG patients than in YOG patients. The pain intensity, distribution of headache diagnoses, and frequency of medication overuse differed according to the age at headache onset.
Age of Onset
;
Aged
;
Classification*
;
Diagnosis
;
Electrooculography
;
Female
;
Headache Disorders*
;
Headache Disorders, Primary
;
Headache Disorders, Secondary
;
Headache*
;
Humans
;
Korea
;
Migraine Disorders
;
Prescription Drug Overuse
;
Prospective Studies
;
Tension-Type Headache
;
Tertiary Care Centers